ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 26 October to 1 November 2026

The 10 most important of the 120 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Cardiology · Lancet · 2026-10-29

In 5 trials (110,933 presentations) of suspected heart attack, the 0/1 h troponin pathway did not clearly differ from 0/3 h on 30-day death or new type 1 MI (0.8% vs 1.0%), and did not shorten emergency department stay.

Meta-analysisn = 110,933 presentations
Boeddinghaus et al. Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials
Orthopaedics and sports medicine · Bone Joint J · 2026-11-01

Meta-analysis of 22 RCTs (28,112 patients) after elective total hip arthroplasty: DOACs vs LMWH lowered VTE (OR 0.62), mainly DVT, but raised overall bleeding (OR 1.19); no bleeding difference for UK-licensed agents and doses. Reoperation and mortality similar.

Meta-analysisn = 28,112
Mohammad et al. A comparison of the efficacy and safety of direct oral anticoagulants with low molecular weight heparin for venous thromboembolism prophylaxis after total hip arthroplasty : a systematic review and meta-analysis

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.